Management of bleeding in the terminally ill patient

Eric Prommer

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Clinically significant bleeding occurs in approximately 6%-10% of patients in the palliative-care setting. Bleeding can range from persistent and small in quantity (but enough to interfere with a patient's quality of life), to catastrophic bleeding that ultimately leads to the rapid demise of the patient. Uncontrolled bleeding can be very distressing for staff, patients and families. Advanced planning is necessary in all bleeding circumstances. This session will review the types of cancer associated with bleeding, as well as management options for these situations. Emphasis will be placed on aspects of communication with families.

Original languageEnglish (US)
Pages (from-to)167-175
Number of pages9
JournalHematology
Volume10
Issue number3
DOIs
StatePublished - Jun 2005
Externally publishedYes

Fingerprint

Terminally Ill
Hemorrhage
Palliative Care
Communication
Quality of Life
Neoplasms

Keywords

  • Bleeding
  • Cancer
  • Terminal illness
  • Therapy

ASJC Scopus subject areas

  • Hematology

Cite this

Management of bleeding in the terminally ill patient. / Prommer, Eric.

In: Hematology, Vol. 10, No. 3, 06.2005, p. 167-175.

Research output: Contribution to journalArticle

Prommer, Eric. / Management of bleeding in the terminally ill patient. In: Hematology. 2005 ; Vol. 10, No. 3. pp. 167-175.
@article{589989dad10d4285990a333c8aa255ab,
title = "Management of bleeding in the terminally ill patient",
abstract = "Clinically significant bleeding occurs in approximately 6{\%}-10{\%} of patients in the palliative-care setting. Bleeding can range from persistent and small in quantity (but enough to interfere with a patient's quality of life), to catastrophic bleeding that ultimately leads to the rapid demise of the patient. Uncontrolled bleeding can be very distressing for staff, patients and families. Advanced planning is necessary in all bleeding circumstances. This session will review the types of cancer associated with bleeding, as well as management options for these situations. Emphasis will be placed on aspects of communication with families.",
keywords = "Bleeding, Cancer, Terminal illness, Therapy",
author = "Eric Prommer",
year = "2005",
month = "6",
doi = "10.1080/10245330500093237",
language = "English (US)",
volume = "10",
pages = "167--175",
journal = "Hematology",
issn = "1024-5340",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Management of bleeding in the terminally ill patient

AU - Prommer, Eric

PY - 2005/6

Y1 - 2005/6

N2 - Clinically significant bleeding occurs in approximately 6%-10% of patients in the palliative-care setting. Bleeding can range from persistent and small in quantity (but enough to interfere with a patient's quality of life), to catastrophic bleeding that ultimately leads to the rapid demise of the patient. Uncontrolled bleeding can be very distressing for staff, patients and families. Advanced planning is necessary in all bleeding circumstances. This session will review the types of cancer associated with bleeding, as well as management options for these situations. Emphasis will be placed on aspects of communication with families.

AB - Clinically significant bleeding occurs in approximately 6%-10% of patients in the palliative-care setting. Bleeding can range from persistent and small in quantity (but enough to interfere with a patient's quality of life), to catastrophic bleeding that ultimately leads to the rapid demise of the patient. Uncontrolled bleeding can be very distressing for staff, patients and families. Advanced planning is necessary in all bleeding circumstances. This session will review the types of cancer associated with bleeding, as well as management options for these situations. Emphasis will be placed on aspects of communication with families.

KW - Bleeding

KW - Cancer

KW - Terminal illness

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=25144469682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144469682&partnerID=8YFLogxK

U2 - 10.1080/10245330500093237

DO - 10.1080/10245330500093237

M3 - Article

C2 - 16019465

AN - SCOPUS:25144469682

VL - 10

SP - 167

EP - 175

JO - Hematology

JF - Hematology

SN - 1024-5340

IS - 3

ER -